Trial Details
Not RecruitingBasic Information
| Clinical ID | c5063 |
|---|---|
| Identifier | EUCTR2020-004012-10-BE |
| Trial Title | Model-informed infliximab dose de-escalation following earlier dose escalation in adult patients with inflammatory bowel diseases - MODIFI |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Inflammatory bowel diseases.- Crohn's disease.- ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: InflectraProduct Name: infliximabPharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: INFLIXIMABCAS Number: 170277-31-3Concentration unit: mg milligram(s)Concentration type: equa |
Participant Information
| Sponsor | UZ Leuven |
|---|---|
| City | NULL |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |